- Home
- IHRT vs BMEA Comparison
IHRT vs BMEA Comparison
Compare IHRT & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHRT
- BMEA
- Stock Information
- Founded
- IHRT N/A
- BMEA 2017
- Country
- IHRT United States
- BMEA United States
- Employees
- IHRT N/A
- BMEA N/A
- Industry
- IHRT Broadcasting
- BMEA Biotechnology: Pharmaceutical Preparations
- Sector
- IHRT Consumer Discretionary
- BMEA Health Care
- Exchange
- IHRT Nasdaq
- BMEA Nasdaq
- Market Cap
- IHRT 296.6M
- BMEA 275.6M
- IPO Year
- IHRT 2019
- BMEA 2021
- Fundamental
- Price
- IHRT $2.40
- BMEA $6.44
- Analyst Decision
- IHRT Buy
- BMEA Buy
- Analyst Count
- IHRT 3
- BMEA 13
- Target Price
- IHRT $3.00
- BMEA $37.25
- AVG Volume (30 Days)
- IHRT 1.3M
- BMEA 816.8K
- Earning Date
- IHRT 11-07-2024
- BMEA 10-29-2024
- Dividend Yield
- IHRT N/A
- BMEA N/A
- EPS Growth
- IHRT N/A
- BMEA N/A
- EPS
- IHRT N/A
- BMEA N/A
- Revenue
- IHRT $3,803,046,000.00
- BMEA N/A
- Revenue This Year
- IHRT $6.56
- BMEA N/A
- Revenue Next Year
- IHRT N/A
- BMEA N/A
- P/E Ratio
- IHRT N/A
- BMEA N/A
- Revenue Growth
- IHRT N/A
- BMEA N/A
- 52 Week Low
- IHRT $0.81
- BMEA $3.61
- 52 Week High
- IHRT $3.12
- BMEA $22.74
- Technical
- Relative Strength Index (RSI)
- IHRT 59.51
- BMEA 25.39
- Support Level
- IHRT $2.24
- BMEA $6.04
- Resistance Level
- IHRT $2.50
- BMEA $9.34
- Average True Range (ATR)
- IHRT 0.24
- BMEA 0.54
- MACD
- IHRT 0.01
- BMEA -0.20
- Stochastic Oscillator
- IHRT 62.23
- BMEA 12.12
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based diversified media and entertainment company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.